Literature DB >> 26790446

Contribution of in vitro comparison of colorectal carcinoma cells from primary and metastatic lesions to elucidation of mechanisms of tumor progression and response to anticancer therapy.

Lukáš Krbal1, Veronika Hanušová2, Jiří Soukup1, Stanislav John3,4, Petra Matoušková5, Aleš Ryška1.   

Abstract

Colorectal cancer has been a leading cause of cancer-related morbidity and mortality. For the research and individualization of therapy, primary cell lines of the colorectal cancer appear to be still an invaluable tool. We evaluated the differences in metastatic potential between four isolated primary colon cancer cells and cells derived from their lymph node metastasis. These results were compared with correspond immortalized cells-SW480 and SW620, respectively. The ability to migrate was tested using real-time measurement in xCELLigence system. Expressions of molecules involved in adhesion and invasion processes were examined using RT-PCR and western blot analysis. Furthermore, impact of cytotoxic effect of selected chemotherapeutics (irinotecan, oxaliplatin) and biological therapy (bevacizumab, cetuximab, panitumumab) was assessed by the WST assay. As expected, cell lines derived from lymph node migrated more aggressively and higher expression of adhesion molecules ICAM-1, EpCAM, and N-cadherin was detected. The expression of MMP-2 and -9 was elevated, on the other hand, in cell lines derived from primary tumor cancer cells as well as the expression of miR-21, miR-29a, and miR-200a. The most pronounced cytotoxic effect has been recorded with oxaliplatin and irinotecan (IC50 = 48.23 resp. 0.11 μg/ml), especially in cells originating from lymph node metastases. In total, comparison of isolated cell lines and immortalized cell lines has shown many similarities, as well as several differences. Adhesion/invasion molecules and several miRNAs, which play an important role in tumor development and the invasive and migratory behavior, could be a useful therapeutic target in malignant colorectal cancer.

Entities:  

Keywords:  Anticancer therapy; Colorectal carcinoma; Lymph node metastasis; Tumor progression; microRNA

Mesh:

Substances:

Year:  2016        PMID: 26790446     DOI: 10.1007/s13277-016-4839-y

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  23 in total

1.  Reduced E-cadherin expression and enlargement of cancer nuclei strongly correlate with hematogenic metastasis in colorectal adenocarcinoma.

Authors:  M Ikeguchi; T Taniguchi; M Makino; N Kaibara
Journal:  Scand J Gastroenterol       Date:  2000-08       Impact factor: 2.423

2.  Principles of cancer cell culture.

Authors:  Ian A Cree
Journal:  Methods Mol Biol       Date:  2011

3.  Prognostic value of E-cadherin, beta-catenin, MMPs (7 and 9), and TIMPs (1 and 2) in patients with colorectal carcinoma.

Authors:  Fernanda Roca; Laura V Mauro; Ana Morandi; Fernando Bonadeo; Carlos Vaccaro; Guillermo Ojea Quintana; Sergio Specterman; Elisa Bal de Kier Joffé; María Guadalupe Pallotta; Lydia Inés Puricelli; José Lastiri
Journal:  J Surg Oncol       Date:  2006-02-01       Impact factor: 3.454

4.  The Prognostic Impact of Protein Expression of E-Cadherin-Catenin Complexes Differs between Rectal and Colon Carcinoma.

Authors:  Rolf Aamodt; Johan Bondi; Solveig Norheim Andersen; Arne Bakka; Geir Bukholm; Ida R K Bukholm
Journal:  Gastroenterol Res Pract       Date:  2010-08-16       Impact factor: 2.260

Review 5.  Technologies for deriving primary tumor cells for use in personalized cancer therapy.

Authors:  Abhisek Mitra; Lopa Mishra; Shulin Li
Journal:  Trends Biotechnol       Date:  2013-04-16       Impact factor: 19.536

6.  Adjuvant therapy of colon cancer--results of a prospectively randomized trial.

Authors: 
Journal:  N Engl J Med       Date:  1984-03-22       Impact factor: 91.245

Review 7.  Angiogenesis modulation in cancer research: novel clinical approaches.

Authors:  Massimo Cristofanilli; Chusilp Charnsangavej; Gabriel N Hortobagyi
Journal:  Nat Rev Drug Discov       Date:  2002-06       Impact factor: 84.694

8.  Immunochemical, biomolecular and biochemical characterization of bovine epithelial intestinal primocultures.

Authors:  Dorina Rusu; Suzanne Loret; Olivier Peulen; Jacques Mainil; Guy Dandrifosse
Journal:  BMC Cell Biol       Date:  2005-12-01       Impact factor: 4.241

Review 9.  Detection of miRNA as non-invasive biomarkers of colorectal cancer.

Authors:  Albert Ren; Yujuan Dong; Ho Tsoi; Jun Yu
Journal:  Int J Mol Sci       Date:  2015-01-27       Impact factor: 5.923

10.  Isolation and characterization of human primary enterocytes from small intestine using a novel method.

Authors:  Priti Chougule; Gustaf Herlenius; Nidia Maritza Hernandez; Pradeep B Patil; Bo Xu; Suchitra Sumitran-Holgersson
Journal:  Scand J Gastroenterol       Date:  2012-09-04       Impact factor: 2.423

View more
  2 in total

1.  LIM and SH3 protein 1 knockdown suppresses proliferation and metastasis of colorectal carcinoma cells via inhibition of the mitogen-activated protein kinase signaling pathway.

Authors:  Hongpeng Zhao; Bo Liu; Jie Li
Journal:  Oncol Lett       Date:  2018-03-09       Impact factor: 2.967

2.  PEG-coated nanoparticles detachable in acidic microenvironments for the tumor-directed delivery of chemo- and gene therapies for head and neck cancer.

Authors:  Yu-Li Lo; Chih-Hsien Chang; Chen-Shen Wang; Muh-Hwa Yang; Anya Maan-Yuh Lin; Ci-Jheng Hong; Wei-Hsuan Tseng
Journal:  Theranostics       Date:  2020-05-17       Impact factor: 11.556

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.